Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMedialis Ltd.

About this trial

We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patient group

Patient is aged ≥18 years at the time of survey completion.

Patient has a BMI over 25 (self-reported)

Patient is willing to participate in all study activities.

Disqualifiers

Participants do not have the cognitive capacity to provide informed consent.

Participants with severe co-morbidity that might affect study participation.

Trial population

Patients with BMI over 25 Healthcare professionals treating patients.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Development of a Disease-Specific Questionnaire

Time frame
2 months

Secondary outcomes

1

Quality of Life Instrument

Time frame
2 months

Other outcomes

1

Cost Implications of Obesity

Time frame
2 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.